Pitfall in diagnosing growth hormone deficiency in a hypochondroplastic patient with a delayed puberty
- PMID: 12784193
- DOI: 10.1055/s-2003-39780
Pitfall in diagnosing growth hormone deficiency in a hypochondroplastic patient with a delayed puberty
Abstract
Hypochondroplasia is a clinically and genetically heterogeneous skeletal dysplasia with less obvious disproportion in childhood and a reduced pubertal growth spurt. We report on a young hypochondroplastic man who had been misdiagnosed and treated as being growth hormone (GH) deficient in the early phase of puberty. The delay of his puberty which is unusual in hypochondroplasia might have confused the results of provocative GH testing. At the age of 17 years measurement of body proportions revealed an increased upper to lower body segment ratio. Skeletal radiographs showed a lack of increase in the interpedicular distance from the first to the fifth lumbar vertebra, anteroposterior shortening of the lumbar pedicles, short femoral necks, a fibula longer than the tibia, and short tubular bones. As the clinical and radiographic features suggested the diagnosis of a skeletal dysplasia, a DNA sequence analysis of the fibroblast growth factor receptor 3 gene on chromosome 4 p16.3 was performed, which identified the missense mutation C1620 G in the tyrosine kinase domain resulting in an Asn540Lys substitution. Hypochondroplastic children with this common mutation (N540K) were previously found to respond to GH treatment with an increase in sitting height compared to leg length, which accentuated the existing disproportion. We want to emphasise that in children with normal serum IGF-I and IGFBP-3 levels accurate measurements of body proportions and skeletal radiographs in disproportionate cases are more important than reiterative GH stimulation tests, which prepubertally and in the early phase of puberty often show subnormal responses.
Similar articles
-
Growth and growth hormone therapy in hypochondroplasia.Acta Paediatr Scand. 1990 Aug-Sep;79(8-9):796-803. doi: 10.1111/j.1651-2227.1990.tb11557.x. Acta Paediatr Scand. 1990. PMID: 2239275
-
Radiographic and genetic diagnosis of sporadic hypochondroplasia early in the neonatal period.Prenat Diagn. 2004 Jan;24(1):45-9. doi: 10.1002/pd.746. Prenat Diagn. 2004. PMID: 14755409
-
Comparison of clinical-radiological and molecular findings in hypochondroplasia.Am J Med Genet. 1998 Jan 6;75(1):109-12. doi: 10.1002/(sici)1096-8628(19980106)75:1<109::aid-ajmg22>3.0.co;2-p. Am J Med Genet. 1998. PMID: 9450868
-
Growth hormone therapy in hypochondroplasia.Acta Paediatr Suppl. 1999 Feb;88(428):116-7. doi: 10.1111/j.1651-2227.1999.tb14368.x. Acta Paediatr Suppl. 1999. PMID: 10102069 Review.
-
Is priming with sex steroids useful for defining patients who will benefit from GH treatment?Pediatr Endocrinol Rev. 2014 Mar;11(3):284-7. Pediatr Endocrinol Rev. 2014. PMID: 24716393 Review.
Cited by
-
Evaluation of Efficacy of Long-term Growth Hormone Therapy in Patients with Hypochondroplasia.J Clin Res Pediatr Endocrinol. 2018 Nov 29;10(4):373-376. doi: 10.4274/jcrpe.0043. Epub 2018 May 9. J Clin Res Pediatr Endocrinol. 2018. PMID: 29739731 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous